F.D.A. Panel Recommends Approval for Gene-Altering Leukemia Treatment by DENISE GRADY
By DENISE GRADY
The panel voted unanimously to recommend that the agency approve a treatment that genetically alters a patient’s own cells to fight leukemia.
Published: July 11, 2017 at 05:00PM
from NYT Health https://www.nytimes.com/2017/07/12/health/fda-novartis-leukemia-gene-medicine.html?partner=IFTTT